Latest Singulair news
FDA: Montelukast Tablet Bottles Recalled
posted September 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Some bottles of montelukast (Singulair) tablets for asthma have been recalled by Camber Pharmaceuticals because they contain the wrong medication, the U.S. Food and Drug Administration says.
Montelukast Associated With Nightmares, Depression
posted September 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Montelukast appears to be linked to neuropsychiatric side effects, such as depression, aggression, nightmares, and headaches, according to a review published online Sept. 20 in Pharmacology Research and Perspectives.
Maternal Night-Shift Work Tied to Later Neurodevelopmental Issues in Offspring 
Study IDs Real-World Reasons for Lemborexant Discontinuation 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Childhood Cancer Survivors Often Have Mental Distress in Adulthood 
Early Survivorship Care Linked to Improved Outcomes in Head, Neck Cancer 
Better Youth Fitness May Lower Risk for Depression in Adulthood 
Exercise Intervention Linked to Improved Attention, Memory in Breast Cancer .jpg)
Cancer Survivors Have Lower Levels of Physical Activity Monthly Specialist Briefings
Stay Connected
